Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Sarepta Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Sarepta_Therapeutics

    Revenue. US$ 1.243 billion (2023) Number of employees. 1,314 (December 2023) Website. sarepta .com. Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, [1] shortly before going public the ...

  3. US FDA approves expanded use of Sarepta's Duchenne gene ... - AOL

    www.aol.com/news/us-fda-approves-expanded...

    June 20, 2024 at 7:07 PM. By Leroy Leo and Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration allowed the expanded use of Sarepta Therapeutics' gene therapy for patients with Duchenne ...

  4. Has Sarepta Therapeutics Become a No-Brainer Stock Buy ... - AOL

    www.aol.com/sarepta-therapeutics-become-no-b...

    By 2025, it could generate $3 billion in sales before reaching a peak of $5 billion in 2027. Last year, Sarepta's top line came in at over $1.2 billion, with the company incurring a $536 million ...

  5. Sarepta surges as investors cheer expanded use of gene therapy

    www.aol.com/news/sarepta-surges-investors-cheer...

    June 21, 2024 at 6:53 AM. (Reuters) - Sarepta Therapeutics shares surged about 36% in premarket trading on Friday as an expanded use approval opened up a bigger market in the U.S. for its gene ...

  6. Battelle Memorial Institute - Wikipedia

    en.wikipedia.org/wiki/Battelle_Memorial_Institute

    Battelle Memorial Institute (or simply Battelle) is a private nonprofit applied science and technology development company headquartered in Columbus, Ohio. The institute opened in 1929 but traces its origins to the 1923 will of Ohio industrialist Gordon Battelle which provided for its creation and his mother Annie Maude Norton Battelle who left ...

  7. Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.

    www.aol.com/finance/pfizers-pain-sarepta...

    Elevidys brought in $133.9 million of Sarepta's haul of $359.5 million in the first quarter of this year, and it's the only treatment of its kind on the market.

  8. List of S&P 400 companies - Wikipedia

    en.wikipedia.org/wiki/List_of_S&P_400_companies

    This is a list of companies having stocks that are included in the S&P MidCap 400 stock market index.The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies.

  9. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!